iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025RALEIGH, NC / ACCESS Newswire / March 21, 2025 / iAccess Alpha's Virtual Best Ideas Spring Investment Conference will take place on March 25-26, 2025, bringing together top micro-cap companies and investors for two days of high-quality insights and investing opportunities.
Life Sciences Virtual Investor Forum Agenda Announced for September 19thCompany Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Protalix and Chiesi Resubmit FDA Application For Rare Disease TreatmentProtalix BioTherapeutics, Inc. (NYSE AMERICAN: PLX), an Israeli biopharmaceutical company, and Chiesi Global Rare Diseases, a business unit of the Chiesi Group, have resubmitted a Biologics License Application (BLA) for pegunigalsidase alfa (PRX–102), a drug candidate for the treatment of adult patients with Fabry disease.
Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment DecisionsAs many investors are aware, options market data can provide some critical insight into future price movements of underlying common stock. It’s often possible to tell how the broader market perceives a company by looking at how options traders are trading it.
